Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer

NCT00842582 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No enrollment. Unable to recruit due to lack of eligible patients.

Conditions

Ovarian Cancer

Interventions

DRUG: Azacitidine
DRUG: Azacitidine
DRUG: Azacitidine

Sponsor

Loyola University

Collaborators

[object Object]